Development of gellan gum-based microparticles/hydrogel matrices for application in the intervertebral disc regeneration by Pereira, D. R. et al.
Development of Gellan Gum-Based Microparticles/
Hydrogel Matrices for Application
in the Intervertebral Disc Regeneration
Diana Ribeiro Pereira, M.Sc.,1,2 Joana Silva-Correia, Ph.D.,1,2 Sofia Glo´ria Caridade, M.Sc.,1,2
Joao T. Oliveira, Ph.D.,1,2 Rui A. Sousa, Ph.D.,1,2 Antonio J. Salgado, Ph.D.,2
Joaquim M. Oliveira, Ph.D.,1,2 Joa˜o F. Mano, Ph.D.,1,2 Nuno Sousa, M.D., Ph.D.,3 and Rui L. Reis, Ph.D.1,2
Low back pain is one of the most reported medical conditions associated to intervertebral disc (IVD) degen-
eration. Nucleus pulposus (NP) is often regarded as the structure where IVD degeneration begins. Gellan gum
(GG)-based hydrogels for acellular and cellular tissue engineering strategies have been developed for finding
applications as NP substitutes. The innovative strategy is based on the reinforcement of the hydrogel matrix with
biocompatible and biodegradable GG microparticles (MPs), which are expected to improve the mechanical
properties, while allowing to tailor its degradation rate. In this study, several GG MP/hydrogel disc formula-
tions were prepared by means of mixing high acyl GG (0.75% (w/v)) and low acyl GG (2% (w/v)) GG aqueous
solutions at different ratios, namely, 75%:25% (v/v), 50%:50% (v/v), and 25%:75% (v/v), respectively. The GG
MP size was measured using a stereo microscope, and their dispersion within the hydrogel matrix was eval-
uated by means of staining the MPs with Toluidine Blue-O. The developed GG MPs/hydrogel discs were
physicochemically characterized by Fourier-transform infrared spectroscopy and 1H-nuclear magnetic resonance
spectroscopy. The swelling behavior and degradation rate were assessed by immersion in a phosphate buffer
saline for 14 days. The morphology and mechanical behavior were investigated by scanning electron microscopy
and dynamic mechanical analysis, respectively. The mechanical properties of the hydrogel disc were improved
by mixing the gels with the MPs. In addition, the possible cytotoxicity of the leachables released by MPs/
hydrogel discs was screened in vitro, using a mouse lung fibroblast cell line (L929 cells). To investigate the
encapsulation efficacy of L929 cells into the GG MPs/hydrogel discs, cells were stained with DAPI blue/Texas
Red-Phalloidin and observed by confocal microscopy, after 24, 48, and 72 h of culturing. A cell viability assay
was also performed using Calcein AM staining. The cell culture studies demonstrated that MPs/hydrogel discs
are noncytotoxic over L929 cells. It was also demonstrated that L929 cells can be successfully encapsulated into
the GG MPs of different formulations, remaining viable after 72 h of culturing. This study showed that GG
hydrogel matrices reinforced with cell-loaded MPs could be a candidate strategy for NP regeneration.
Introduction
The tremendous increase in the number of patientssuffering from low back pain (LBP) demands reliable
clinical solutions urgently. Against a backdrop of intensive
research, the consensus among how to best treat LBP still
remains undefined.1–3
Human disability and suffering correlated with LBP is
mainly caused by failure and degeneration of the interver-
tebral disc (IVD). The ability of the IVDs to move between
spinal segments enables the spinal column to support dis-
similar forces and massive loads.4,5 Centrally situated into
the IVD structure, nucleus pulposus (NP) is a gelatinous
tissue surrounded by the annulus fibrosus (AF) on the radial
periphery. These structures are sandwiched between two
cartilaginous endplates, in both superior and inferior faces,
which all together forms the IVD. After the age of 30, no
blood vessels are present, which thus predisposes to IVD
degeneration (IDD).6 Concentric lamellae of AF are composed
mainly by collagen type I and elastin radially organized,
whereas the highly hydrated NP is primarily constituted
by collagen type II.7 The gel-like NP compartment contains
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proteoglycans (PGs) such as versican, biglycan, decorin, fi-
bromodulin, luminican, and especially aggrecan.8 The lim-
ited IVD self-repair capacity results from the fact that nerves
and blood vessels are mainly confined to AF. The environ-
ment around NP cells generally lacks nutrients, oxygen,
glucose, and removal of waste products. Further, in the NP,
cells are sparsely separated and are present in low number
(5 · 103 cells/mm3).9 Disc-related pain is possibly associated
with compression of the nerve route or irritation, stenosis
and spondylolisthesis, and loss of disc weight.10,11 The tra-
ditional medical therapies for treating chronic patients are
contributing for increasing medical costs. Current treatments
of IDD concern the relief of symptoms, mainly pain and do
not underlie the associated biological NP changes. Mono-
therapies, such as well-defined pain-relieving pharmaceuti-
cals, and traditional procedures to treat IVD disorders (e.g.,
bone fusion and discectomy) have been used, which have
shown long-term ineffectiveness.4 NP regeneration can be
achieved following a tissue engineering (TE) strategy, which
by definition proposes combination of biomaterials, cells,
and bioactive molecules. This therapeutic strategy, should
promote a natural repair process and restoration of healthy
functions.12,13 TE approaches are currently underway; still, it
has not been possible to create a functional NP. This is
mainly attributed both to incapacity to apply pressures
mimicking the natural environment and insufficient knowl-
edge of the complex IVD molecular functions.14,15 Moreover,
inadequate biomechanical behavior and integration of both
new and native tissue are usually difficult to achieve.12,16 The
development of injectable systems that enables encapsulat-
ing cells and that mimics the NP biological and biome-
chanical characteristics has been attracting great deal of
attention.17,18 Hydrogels have been used for NP TE appli-
cations mainly due to its ability to swell and retain high
amounts of water. Cell-based implants have been developed
to promote in situ regeneration of NP by resembling its
natural structure.19–22 The combination of biological and
biomechanical requirements have been addressed to restore
the natural functions (i.e., physiological load distribution,
and viscoelastic and transport properties) in a degenerated
NP. Hydrogels (gel-like behavior) are promising materials to
be used as IVD substitutes due to its similarity to the ana-
tomic framework or extracellular matrix and hydrophili-
city.23 The use of a hydrogel as NP substitute is also
advantageous, as it enables to be implanted using minimally
invasive techniques, while restoring the disc volume. More-
over, hydrogels can be obtained using both nonharsh
methods and reagents. The reinforcement of such hydrogels
with microparticles (MPs) can improve the mechanical
properties. Further, encapsulation of cells and/or biomole-
cules on MPs loaded on hydrogel matrices can enhance their
biological performance. Nowadays, a variety of NP substi-
tutes mimicking the native tissue have been synthesized
from alginate,24,25 collagen,26,27 Gellan gum,17,28 fibrin,29
gelatin,30 etc., to allow the formation of neo tissue.
Gellan gum (GG) is a polysaccharide derived by fermen-
tation of bacterium Spinghomonas elodea, which has been
proposed for TE strategies.17,28,31–33 Two different types of
GG are available: the acylated (high acyl Gellan gum,
HAGG) and deacylated (low acyl Gellan gum, LAGG) forms.
Both isoforms are composed of repetitive units of glucose,
glucuronic acid, and rhamnose, including one carboxyl side
group.34 Both forms of GG are distinguishable concerning
the gels they produce. HAGG originates soft, elastic, and
nonbrittle gels, whereas LAGG produces hard, nonelastic,
and brittle gels. The process of hydrogel formation proce-
dure enables GG to assume a three-dimensional (3D) net-
work structure.23,35,36 At moderately high temperatures, GG
chains are in a random-coil state, and by means of decreasing
temperature, a transition from random-coil to double-helix
occurs. After that, a structure made up of anti-parallel self-
assembled double helices is formed producing oriented
bundles called junctions zones. The untwined sites of the GG
chains link the junction zones, thus originating a 3D frame-
work. However, the gelation of such polysaccharide is
strongly affected by the type and concentration of the ions,
and thus these parameters should be considered when pre-
paring GG hydrogels. Ionic-crosslinked hydrogels have a
high mechanical stability due to the presence of multivalent,
usually divalent, cations. The gelation in the presence of di-
valent cations allows the formation of more strongly cross-
linked hydrogels than monovalent cations.33,37,38
MPs have been widely studied to engineer systems capa-
ble to deliver biomolecules, drugs, or cells.39 To encapsulate
living cells, different polymeric systems, for example, algi-
nate spheres, have been proposed.40 The noncytotoxicity,
semi-permeability, and immune protection given by these
systems allow to foresee their use in feasible approaches.
Thus, the hydrogel matrix reinforced with MPs arises as a
new approach for cell encapsulation, which also allows for
the improvement of the mechanical properties.
In the present work, the main purpose concerned the de-
velopment of a novel GG hydrogel system, consisting of GG
MPs dispersed in a GG matrix, for finding application as an
NP substitute in the regeneration of IVD. Several formula-
tions of both GG forms (HAGG and LAGG) were prepared
and gelation achieved by means of ionic-crosslinking using a
phosphate-buffered saline (PBS, pH 7.4). The MPs processed
were expected to improve the mechanical properties of the
matrices. Therefore, mechanical behavior of the different
formulations of GG MPs/hydrogel discs was investigated by
dynamic mechanical analysis. The swelling behavior and
degradation rate of the developed GG MPs/hydrogel discs
were assessed by immersion in PBS (pH 7.4), over a period of
14 days. The possible cytotoxicity of the leachables released
by the MPs/hydrogel discs was screened in vitro by means of
using a mouse lung fibroblast cell line (L929 cells), after 72 h
of culturing. Cell-loaded MPs/hydrogels were produced by
preparing MPs loaded with cells, which were then incorpo-
rated into the different GG matrices. To qualitatively inves-
tigate the encapsulation efficacy of L929 cells into the GG
MPs/hydrogel discs, a staining with DAPI blue/Texas Red-
Phalloidin was performed, after 24, 48, and 72 h of culturing.
A Live/Dead cell viability assay was also carried out (Cal-
cein AM staining), followed by confocal microscopy obser-
vations.
Materials and Methods
Materials
LAGG (Gelzan CM) was purchased from Sigma-Aldrich
and HAGG (KelcoGel LT100) from CP Kelco. Unless other-
wise stated, all the reagents were purchased from Sigma-
Aldrich.
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GG MPs processing
Different formulations of GG MPs were obtained by
means of combining 0.75% (w/v) HAGG and 2% (w/v)
LAGG aqueous solutions at a ratio of 75%:25%, 50%:50%,
and 25%:75% (v/v), respectively. GG solutions were pre-
pared at room temperature. Each formulation was dissolved
in distilled water at room temperature under constant stir-
ring, for 24 h. To promote the complete dissolution of the
powders, all solutions were agitated using an Ultra-turrax
(Yellow Line DI 18B; Qlab) equipment, for 20min.
Different GG MPs were produced by means of using a
precision syringe pump (Fusion 200; Chemyx Inc.). A 1mL
syringe with an attached needle of 25G was filled with each
GG formulation, and set in the syringe pump. A precipita-
tion rate of 8mL/min was used, and GG MPs were obtained
by precipitation in a PBS (pH 7.4) solution, under agitation.
Then, MPs were collected by filtration.
Preparation of the GG MPs/hydrogel matrices
Discs of the GG MPs/hydrogel for all three formulations
were prepared by ionic-crosslinking in PBS. Each batch was
composed by MPs and matrix, both obtained from the same
formulation (i.e., 75%:25%, 50%:50%, or 25%:75% [v/v]
HAGG:LAGG). Molds of silicone tube (height, 4 mm; di-
ameter, 7mm) were sterilized and filled with*200mL of the
hydrogel previously mixed with MPs. Then, the molds were
placed in a Petri dish and immersed in PBS to allow reticu-
lation. As controls, discs without MPs were also prepared.
Physicochemical characterization of the LAGG
and HAGG MPs/hydrogel matrices
Fourier-transform infrared spectroscopy. Fourier-transform
infrared (FTIR) analysis was performed in HAGG and LAGG
scaffolds using an IRPrestige-21 spectrometer (Shimadzu
Corporation). The freeze-dried hydrogel discs were previ-
ously powdered and mixed with potassium bromide (KBr;
Riedel-de Hae¨n) to obtain transparent KBr pellets in the ratio
of 1:10 of sample/KBr (w/w).41 Then, the pellets were pro-
duced by uniaxially pressing the powders. Spectra were re-
corded in the range 4400–800 cm - 1 using an average of 32
scans at a resolution of 2 cm- 1. The FTIR graphs were ob-
tained using Origin Pro8 software (OriginLab).
1H-nuclear magnetic resonance spectroscopy. 1H-nuclear
magnetic resonance (NMR) analysis was performed with a
Varian Unity Plus spectrometer (equipped with a variable
temperature system) operating at 300MHz to investigate
HAGG and LAGG chemical structures. The samples were
prepared dissolving 10mg of each freeze-dried hydrogel
discs in 1mL of deuterium oxide (D2O), and the spectra
were recorded at 70C. The peak assigned at 4.3 ppm (D2O)
was used as reference. Graphic analysis of obtained data
was performed using MestreNova software (Mestrelab
Research).
MP size and distribution within the hydrogel matri-
ces. The size of the GG MPs and distribution within the
hydrogel matrices was investigated using a stereo micro-
scope (Stemi 1000 PG-HITECH; Zeiss). GG MPs were ob-
served before and after mixing with the hydrogel matrices.
MPs alone were dispersed in a glass slide and observed
under the stereo microscope. Each MPs image was obtained
at 5 · of magnification. The mean particle size was calculated
in each provided image by measuring the diameter of each
MP. The measurement of each MP was performed using the
ImageJ software. To investigate the distribution of MPs within
the hydrogel matrices, the MPs were stained with 1% (w/v)
Toluidine Blue-O (Sigma) before incorporation into the hy-
drogel matrix. The hydrogel matrices loaded with the stained
MPs were then observed under the stereo microscope.
Dynamic mechanical analysis. The viscoelastic mea-
surements were performed using a TRITEC8000B DMA from
Triton Technology equipped with the compressive mode, to
characterize the mechanical behavior of different formula-
tions of GG hydrogel discs (combining HAGG and LAGG).
For Dynamic mechanical analysis (DMA), GG MPs/hydro-
gel matrices were produced incorporating 5, 50, or 500mg/
mL of MPs. The measurements were carried out at 37C.
Samples with cylindrical shapes around 7mm diameter and
4mm thickness were produced accurately for each sample.
The different GG MPs/hydrogel and GG hydrogel discs
were analyzed by immersion in a liquid bath contained in a
Teflon reservoir. The geometry of the samples was then
measured, clamped in the DMA apparatus, and immersed in
the PBS. After equilibration at 37C, the DMA spectra were
acquired during a frequency scan between 0.1 and 10Hz.
The experiments were performed under constant strain am-
plitude (50mm). A small preload was applied to each sample
to ensure that the entire scaffold surface was in contact with
the compression plates before testing. For all scaffolds being
tested, the distance between plates was equal. The DMA
analysis was performed in three samples for each condition.
Swelling behavior and degradation study. For swelling
and degradation studies, 50mg/mL of MPs was incorpo-
rated into the hydrogel matrices. The hydrogels’ swelling
ability was investigated by means of soaking the lyophilized
GG hydrogel discs (n = 3) in PBS. This study was performed
at 37C under constant shaking (60 rpm) for 15 days. The
swelling ability of each hydrogel formulation was calculated
based on the changes of the initial dry mass (mi), after in-
cubation in PBS. Swollen hydrogel discs were removed from
PBS, and analyzed at different time points. The excess of
fluid was eliminated using a filter paper and the wet mass
(mw) weighted using an analytical balance. After that, the
scaffolds were frozen at - 80C and freeze-dried. After
freeze-drying, the scaffolds were weighted and the final dry
mass was determined (md) to calculate weight loss. To de-
termine the percentage of water uptake of the scaffold (WUs)
after each time point (t), and the percentage of weight loss of
the scaffold (WLs) after each time point (t), Equations (1) and
(2) were applied, respectively:
WUs, t(%)¼ [(mw, tmi)=mi]· 100 (1)
WLs, t(%)¼ [(mimd, t)=mi]· 100 (2)
The studies were performed using three samples per ex-
perimental condition (n = 3).
Scanning electron microscopy. All formulations of the
GG hydrogel discs were frozen at - 80C after production,
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and freeze-dried to investigate their morphology. Before
observation, the specimens were sputter coated with a mix-
ture of gold-palladium. A Nova NanoSEM 200 microscope
(FEI) with an attached energy dispersive spectrometer
(Pegasus X4M) was used. The equipment was operated at an
accelerating voltage of 5 kV, and images were captured at
200 · , 1000 · , and 10,000· of magnification.
In vitro studies
Two-dimensional in vitro studies: screening cytotoxicity
(MTS assay). The cytotoxicity of the different GG hydrogel
matrices, with or without MPs, was assessed using an im-
mortalized mouse lung fibroblasts cell line (L929) purchased
from European Collection of Cell Cultures (ECACC). The
effect of the leachables released from the materials (within a
24 h extraction period) on cellular metabolism was per-
formed using a standard MTS (3-(4,5-dimethylthiazol-2-yl)-
5(3-carboxymethoxyphenyl)-2(4-sulfofenyl)-2H-tetrazolium)
(Cell Titer 96 Aqueous Solution Cell Proliferation Assay;
Promega) viability test in accordance with ISO/EN 10993
part 5 guidelines.42 This assay was performed to investigate
the possible cytotoxicity of the several GG hydrogel matrices.
This assay is based on the bioreduction of the substrate
(MTS) that is converted into a brown formazan product by
metabolically active cells, specifically, in presence of dehy-
drogenase enzymes.43 The GG matrices, with or without
MPs, were produced as aforementioned, under sterile condi-
tions. A minimum of 4 g of each material was incubated for
24h in 20mL of complete Dulbecco’s modified Eagle’s me-
dium (DMEM; Sigma) in a thermostatic bath (37C) with
constant shaking (60 rpm) to produce the extracts. A latex
rubber extract was used as positive control for cell death, and
complete culture medium was used as negative control re-
presenting the ideal situation for cell proliferation. The cells
were grown in monolayer in DMEM culture medium sup-
plemented with 10% fetal bovine serum (FBS, heat-
inactivated; Biochrom) and 1% of an antibiotic–antimycotic
mixture (Invitrogen). A chemical method using trypsin (0.25%
trypsin-EDTA solution; Sigma) was used to promote cell de-
tachment from the culture flasks. L929 cells seeded at a den-
sity of 1· 105 cells/well into a 48-well plate (200mL/well)
were incubated for 24h at 37C in a humidified atmosphere of
5% CO2. After that, culture medium was replaced with 200mL
of each extraction fluid. The MTS assay was performed after
culturing the cells in the presence of the extraction fluids for
24, 48, and 72h, under standard culture conditions. A mixture
of serum-free culture medium without phenol red and MTS
(CellTiter 96 One Solution Cell Proliferation Assay Kit; Pro-
mega) was put in contact with the cells.
The optical density (OD) was measured at 490 nm in a
microplate reader (Molecular Devices) with n = 4, two inde-
pendent times. The percentage of cell viability was calculated
after normalization with the mean OD value obtained for the
negative control.
3D in vitro studies: Cell-loaded GG MPs/hydrogel matrices
(constructs). To obtain the cell-loaded MP/hydrogel ma-
trices, an immortalized mouse lung fibroblast cell line (L929)
purchased from European Collection of Cell Cultures
(ECACC) was first encapsulated into the GG MPs. L929 cells
were grown in monolayer in complete DMEM culture me-
dium (Sigma) supplemented with 10% FBS (heat-inactivated;
Biochrom) and 1% of an antibiotic–antimycotic solution (In-
vitrogen). A chemical method using trypsin (0.25% trypsin-
EDTA solution; Sigma) was used to promote cell detachment
from the culture flasks, after the cells have reached confluency.
A cell suspension containing 2.5· 106 cells/mL was prepared,
and then centrifuged at 1200 rpm for 5min. Afterward, the
culture medium was completely aspirated, and the cell pellet
was re-suspended in each GG hydrogel formulation, using a
volume of 1mL. The mixture of cells and hydrogels was
centrifuged at 600 rpm for 3min to promote cells homogeni-
zation. Then, a 1mL syringe was filled with each hydrogel
formulation (cells+hydrogels). To process standardized MPs,
each MPs batch was produced at 50mL/min rate. The rate
used to precipitate MPs was increased in the cellular approach
to accelerate the process, avoiding cell damage or even death.
Different formulations of MPs loaded with L929 cells were
obtained by precipitation in PBS, and equilibrated for 30min.
Then, the MPs were collected for further incorporation within
the hydrogel discs as previously described.
Confocal microscopy (DAPI/TEXAS RED-PHALLOIDIN
staining). Confocal microscopy was performed to obtain
3D images of the cells distributed within the GG MPs/
hydrogels matrices. Images were acquired using an Olympus
Fluoview 1000 confocal microscope (Olympus).
After different times of culturing in standard conditions,
the culture mediumwas aspirated and the cell-loaded GGMPs/
hydrogel matrices were collected. Afterward, the samples were
stained with 4,6-Diamidino-2-phenyindole, dilactate (DAPI;
Sigma). The DAPI solution was removed, and the same hy-
drogels were stained with Phalloidin-Tetramethylrhodamine B
isothiocyanate (Texas Red-Phalloidin; Sigma). The software
FV10-ASW 2.0 Viewer was used to provide confocal images and
videos (provided as Supplementary Data; Supplementary Data
are available online at www.liebertonline.com/tec).
Inverted microscopy (CALCEIN AM staining). After each
period of culturing in standard conditions, cell viability was
assessed by staining the cell-loaded GG MPs/hydrogel ma-
trices with Calcein AM (Molecular Probes). Briefly, the
constructs were incubated in DMEM without phenol red for
24, 48, and 72 h. After each culture period, the constructs
were stained by adding 2mL of Calcein AM and 1mL of
DMEMwithout phenol red. To allow membrane permeation,
the constructs were incubated for 10min. The green fluo-
rescence was observed in an Olympus IX81 inverted micro-
scope (Olympus). The images of Calcein AM staining were
analyzed using the cellB basic imaging software (Olympus).
Statistical analysis. Statistical analysis (GraphPad Prism;
GraphPad Software) concerning the MTS assay was per-
formed using one-way analysis of variance followed by Tu-
key’s post-test with a significance set at p< 0.05. The data on
the MPs size were analyzed using Student’s t-test with a
statistical significance set at p < 0.05. All results are presented
as the mean– standard deviation.
Results
In this study, different formulations for processing GG-
based MPs (MPs)/hydrogel matrices were produced com-
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bining LAGG and HAGG. HAGG and LAGG solutions were
mixed at different ratios (75%:25%, 50%:50%, and 25%:75%
[v/v] HAGG:LAGG). MPs were obtained from these for-
mulations by using a syringe pump for precipitation in PBS.
To preserve the molecular structure of both GG forms, the
method was temperature independent; that is, the solutions
did not need to be heated to allow the complete dissolution
of the powders as it was proposed in the work performed by
Oliveira et al.33 Instead, we used an Ultra-turrax equipment
to facilitate the dissolution of both forms of GG. Both MPs
and GG MPs/hydrogel matrices were equilibrated in PBS for
inducing the ionic-crosslinking of the hydrogels.
Physicochemical characterization of the LAGG
and HAGG MPs/hydrogel matrices
The physicochemical analysis of all GG MPs/hydrogel
matrices was assessed by using different characterization
techniques. FTIR spectroscopy is used to identify the pres-
ence and the environment of functional groups in organic
molecules. It is the simplest and most reliable method to
obtain the characteristic absorption bands of functional
groups. The typical bands of GG were present in both forms
(HAGG and LAGG) at 3473 cm- 1, 2920 cm - 1, 1618 cm - 1,
1536 cm- 1, 1412 cm- 1, and 1037 cm - 1 (Fig. 1 and Table 1). To
confirm the presence of the acyl groups in HAGG, GG
samples were analyzed by 1H NMR spectroscopy (Fig. 2).
The chemical shift for both forms has revealed characteristics
peaks at 5.15, 1.32, 4.73, and 4.55 ppm. In addition, the
HAGG spectra also revealed a peak at 2.19 ppm.
The MPs were produced in an automated drop-by-drop
system, that is, a syringe pump. Macroscopically, it was
possible to observe that the particle size did not varied sig-
nificantly for the different hydrogel formulations (Table 2).
From Figure 3, it was possible to observe that MPs present
a tear shape. The quantity of MPs incorporated into the
hydrogel matrices could represent a factor of stability/
instability; therefore, MPs quantification should be consid-
ered to assure the total integrity and cohesion of the struc-
ture. To better understand the performance of the hydrogels
reinforced with MPs, three different approaches were con-
sidered for each formulation. Different quantities of MPs
were used to reinforce the GG hydrogel matrices: 5, 50, and
500mg/mL. It was possible to verify macroscopically the
nonintegrity of the hydrogels reinforced with MPs at a con-
centration of 500mg/mL. The matrix was not surrounding
the MPs and some of them were found in PBS a few hours
FIG. 1. Fourier-transform
infrared spectra of (A) High
acyl Gellan gum (HAGG) and
(B) Low acyl Gellan gum
(LAGG) powders. The peak
at 1748 cm- 1 is assigned to
the C-O stretching of acyl
group at HAGG. Peaks as-
signment is shown in Table 1.
FIG. 2. 1H-nuclear magnetic resonance spectra of (A)
LAGG and (B) HAGG.
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after being processed, which revealed a poor cohesion of the
MPs within the hydrogel matrix. Figure 4 shows the incor-
poration of 50mg/mL of MPs within the hydrogel matrix. The
MPs were previously stained with Toluidine Blue-O at a
concentration of 1% (w/v), and then incorporated into the
hydrogel matrix. As it can be observed in Figure 4, the MPs
incorporated into the hydrogel discs were sparsely distributed.
Dynamic mechanical analysis (DMA) was performed to
study the effect of the incorporation of the MPs within the
GG hydrogel matrices (Fig. 5). The DMA analyses were
performed on samples in the wet state, and in a hydrated
environment (PBS). The mechanical behavior was assessed
throughout a physiological relevant frequency range (0.1–
10Hz). The reinforcement of GG hydrogel matrices with GG
MPs was evaluated by using three different quantities of
MPs: 5, 50, and 500mg/mL of MPs were incorporated to
each hydrogel formulation. LAGG hydrogel matrices at 2%
(w/v) and hydrogel matrices of each formulation without
MPs were used as controls.
To evaluate the water uptake ability and weight loss of the
GG MPs/hydrogel matrices, in vitro studies were performed
in PBS for 14 days (Fig. 6). In Figure 6A, the capacity of GG
hydrogel matrices to absorb water is presented. Regarding
these results, the hydrogel matrices comprising 50%
HAGG:50% LAGG (v/v) have shown a significantly higher
water uptake ability than the other formulations. Actually,
the water uptake ability of the GG hydrogels after 14 days
ranged from 2000% up to *4000%. Figure 6B shows the
weight loss of the different GG formulations. From this fig-
ure, it is possible to observe a similar behavior for all the GG
hydrogel matrices. However, the GG hydrogel matrices
comprising 75% HAGG:25% LAGG (v/v), with and without
MPs reinforcement, have revealed a significantly higher
degradation as compared to the other formulations.
The morphology of the freeze-dried GG hydrogel matrices
was assessed under scanning electron microscopy (SEM)
(Fig. 7). A highly porous 3D sponge-like morphology was
observed in the cross-sectional images of all discs. However,
there was an increase in pore size by means of increasing the
percentage (v/v) of LAGG at 2% (w/v) in the formulations.
From the SEM images corresponding to LAGG and HAGG
(Fig. 7D and E, respectively), it is possible to observe that
pore size and quantity are completely different. Freeze-dried
LAGG formulation presents larger pores, whereas HAGG
possesses many pores of smaller diameter.
Two-dimensional in vitro studies: Screening cytotoxicity
(MTS assay)
Different assays can be performed to assess the cytotox-
icity in vitro. An immortalized mouse lung fibroblast cell line
(L929 cells) was used to preliminarily screen the possible
cytotoxicity of the materials.42 All the GG hydrogel formu-
lations showed no significant differences as compared to the
negative control (Fig. 8).
In vitro 3D study: Cell-loaded GG MP/hydrogel
matrices (constructs)
The constructs were stained with DAPI blue (nucleus
staining) and Texas Red-Phalloidin (cytoskeleton staining) to
verify the efficiency of the encapsulation process. From the
confocal microscopy images shown in Figure 9, it is possible
to confirm the presence of cells loaded into the MPs in all
formulations. MPs delimitation was not possible to observe
since the MPs were integrated in a hydrogel matrix obtained
from the same formulation. Despite, a round shape formed
by the stained cells was observed, which indicates that cells
are confined to the MPs. Moreover, although the cells were
present in the MPs at different time points, the quantity of
cells did not rise up throughout the time.
To assess cell viability, cell-loaded MPs/hydrogel matrices
were stained with Calcein AM. This compound is able to
permeate the plasma membrane and be converted into Cal-
cein by metabolically active cells. The cleavage of such
fluorochrome by intracellular esterases results in the emis-
sion of green fluorescence that can be observed under a
fluorescence microscopy apparatus.44 Calcein AM assay was
performed at different time points of culture (Fig. 10). In all
FIG. 3. Macroscopic images of
the microparticle (MP) size
made up by different formula-
tions: (A) 75% HAGG:25%
LAGG, (B) 50% HAGG:50%
LAGG, and (C) 25% HAGG:75%
LAGG. The MP size is shown in
Table 2.
FIG. 4. Typical image of the GG MP/hydrogel discs. Dis-
persion of MP at a concentration of 50mg/mL within the
GG-hydrogel discs. MPs were stained with Toluidine Blue-O
before being mixed with the GG matrix. GG, Gellan gum;
MP, microparticles. Color images available online at www
.liebertonline.com/tec
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FIG. 5. Dynamic mechanical analysis of GG-based hydrogel/matrices made up by different formulations: (A–C) graphs
corresponding to storage modulus (E¢): 75% HAGG:25% LAGG, 50% HAGG:50% LAGG, and 25% HAGG:75% LAGG,
respectively and (D–F) graphs corresponding to loss factor (tan d): 75% HAGG:25% LAGG, 50% HAGG:50% LAGG, and 25%
HAGG:75% LAGG, respectively.
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formulations, positive results (green fluorescence) were ob-
tained at different time points, which indicate that cells are
alive.
Discussion
The use of different GG forms for developing hydrogel
substitutes to NP regeneration presents the advantage of
enabling to be implanted using minimally invasive tech-
niques. The combination of LAGG and HAGG was per-
formed with the rationale that HAGG could allow the
tailoring of hydrogel degradation rate, as well as the im-
provement of cellular metabolic activity. Moreover, the in-
corporation of MPs in the GG hydrogels is expected to
improve their mechanical properties. The mild conditions
used to obtain the hydrogel formulations were considered an
important modification of the previous method,31–33 avoid-
ing the heating of the solutions at high temperatures, which
can be deleterious for cell encapsulation and viability. So, in
this study, cell encapsulation was performed by means of
dissolving GG at room temperature, thus avoiding cell
damage or even death. Despite, there is the need to carry out
further studies to elucidate the influence of hydrogel tem-
perature on cells viability during the encapsulation step. To
our knowledge, the reinforcement of such hydrogel matrices
with MPs is herein proposed for the first time, and aims to
improve the mechanical properties of the hydrogel systems,
while allowing cells encapsulation in mild conditions.
Physicochemical characterization of the LAGG
and HAGG MPs/hydrogel matrices
In this work, LAGG and HAGG were first physicochem-
ically characterized by FTIR. The degree of acylation is di-
rectly related with the properties of the GG hydrogel. The
native form of GG (HAGG) implies a critical control of the
structure and it can presents some purity issues.38 The ab-
sorption band at 1618 cm- 1 corresponds to the glycosidic
bond in GG (LAGG and HAGG).41 In the FTIR spectra of
HAGG, it was observed a peak at 1748 cm- 1, which did not
FIG. 7. Scanning electron
microscopy images of the
freeze-dried GG hydrogel
formulations: (A) 25%
HAGG:75% LAGG, (B) 50%
HAGG:50% LAGG, (C) 75%
HAGG:25% LAGG, (D)
LAGG 2%, and (E) HAGG
0.75%.
FIG. 6. (A) Water uptake and (B) weight loss of different GG formulations: LAGG 2%; 75% HAGG:25% LAGG, 50%
HAGG:50% LAGG, 25% HAGG:75% LAGG, 75% HAGG:25% LAGG (50mg/mL MPs); 50% HAGG:50% LAGG (50mg/mL
MPs), and 25% HAGG:75% LAGG (50mg/mL MPs).
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appeared in LAGG spectra (Table 1). This is a characteristic
peak of the acyl group, which is present in the molecular
structure of HAGG.
The acyl groups integrating the HAGG structure were also
verified through analysis of 1H NMR spectra. The chemical
shift for LAGG and HAGG has revealed characteristic peaks
at 5.15 and 1.32 ppm, assigned to H-1 and H-6 of the a-
anomers of L-rhamnopyranosyl residue.45 Moreover, signals
at 4.73 and 4.55 ppm, corresponding to D-glucopyranosyl
and D-glucopyranosyl residues, respectively, were observed
in both 1H NMR spectra. In addition, the HAGG spectra
revealed a peak at 2.19 ppm, which should be attributed to
the acyl groups of HAGG.45
The shape in the form of a tear presented by the MPs can
be attributed to the processing method (i.e., using a syringe
pump) and to the high viscosity of the hydrogel formula-
tions. The size of MPs is an important feature when con-
sidering their use in encapsulating processes. The size kept at
‘‘micro’’ scale is optimal for allowing the encapsulation of
cells. However, a statistically significant difference was
found between the dimensions of the MPs of the different
formulations. The significant differences observed can be
related with the high viscosity of the formulation, which
varies according to the percentage of HAGG and LAGG.
However, it is possible to conclude about the feasibility of
this method to obtain MPs in a standard way. The hydrogel
matrices reinforced with MPs should exhibit total construct
integrity. Nevertheless, the quantity of MPs reinforcing the
hydrogels is an important feature to develop suitable MPs/
hydrogel matrices. Moreover, the dispersion of such MPs
inside the hydrogel matrix is also critical: they might be
sparsely distributed, to avoid different properties in respect
to both mechanical and biological performance.
The reinforcement of hydrogels matrices with cell-loaded
MPs should tackle some requirements: matrices should ex-
hibit a suitable mechanical and biological behavior and
preferentially resemble the native NP.
Succinctly, DMA analysis revealed that the storage mod-
ulus of all hydrogel formulations increased by means of in-
creasing frequency. However, the behavior of the hydrogels
resembled a viscoelastic material in contrast to the human
IVD, which reveals a linear viscoelasticity during com-
pression.46 However, Leahy and Hukins47 have reported a
similar increase in the storage modulus of a sheep model.
Silva-Correia et al.17 reported a storage modulus of 89.5–7.4kPa
for ionic-crosslinked methacrylated GG (GG-MA) hydrogels.
Regarding the loss factor of those hydrogels the values were
around 0.15 and 0.21 at 1Hz. A new approach based on GG
hydrogels was used throughout the reinforcement of the
hydrogels with MPs. Through analysis of DMA data, it was
possible to observe the efficient reinforcement produced by
50mg/mL of MPs in all GG MPs/hydrogel matrices. From
those results, the formulation of 25% HAGG:75% LAGG (v/
v) presented a better performance as compared to the other
FIG. 9. Confocal microscopy
images of the L929 cells en-
capsulated within the differ-
ent GG MPs loaded into GG
discs: (A) LAGG 2%, (B) 75%
HAGG:25% LAGG (50mg/
mL MPs), (C) 50%
HAGG:50% LAGG (50mg/
mL MPs), and (D) 25%
HAGG:75% LAGG (50mg/
mL). All the GG MPs/hydro-
gel matrices were cultured for
24 until 72 h (blue color [DAPI
blue] corresponds to cells nu-
clei; red color [Tex Red Phal-
loidin] is attributed to the
stained cells cytoskeleton).
Color images available online
at www.liebertonline.com/tec
FIG. 8. Cytotoxicity screening of the different formulations
of the different formulations of GG hydrogel with or without
MP leachables using rat lung fibroblasts (L929 cells). Latex
extract (Latex) and standard culture medium were used as
positive and negative controls, respectively. An MTS assay
was performed after 24, 48, and 72 h.
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formulations in respect to mechanical properties. The storage
modulus at 1Hz for 75% HAGG:25% LAGG (v/v) (52.7 –
2.33 kPa), 50% HAGG:50% LAGG (v/v) (37.9 – 5.9 kPa), and
25% HAGG:75% LAGG (v/v) (86.2 – 5.75 kPa) corresponding
to an incorporation of 50mg/mL of MPs demonstrated the
efficacy in improving the mechanical properties of the ma-
trices. In fact, it was also seen that the mechanical properties
of the GG hydrogels were lower when no MPs were incor-
porated into the gels or when MPs are mixed at a final
concentration of 5 and 500mg/mL. The GG MPs/hydrogel
matrices made using the formulation 25% HAGG:75%
LAGG (v/v) reinforced with 50mg/mL of MPs have re-
vealed values for the storage modulus identical to the ones
obtained for GG-MA.17 However, no GG formulation pre-
viously reported elsewhere performed better than LAGG at
2% (119.2 – 13.2 kPa). The optimal outcome to reinforce GG
matrices may be in the range of 50–500mg/mL of incorpo-
rated MPs. However, the concentration of 500mg/mL of
MPs to reinforce the matrices is, in our point of view, ex-
tremely high to promote the reinforcement, since during our
studies it was possible to verify that MPs were already dis-
persed in PBS, before analysis. This fact demonstrated that
the GG MPs/hydrogel matrices reinforced with 500mg/mL
have shown noncohesion and loss of integrity. The loss factor
(tan d) is often considered as a measure of damping capa-
bility of the material. In all formulations incorporated with
500mg/mL of MPs, it was also possible to verify the low
damping properties of those GG MPs/hydrogel matrices.
The incorporation of a viscoelastic material (MPs) within
another viscoelastic material (matrix) changed the loss factor
for undesired values. LAGG at 2% (w/v) showed the better
damping behavior among all gels, with values of 0.12 –
0.0099. The reinforcement of the formulations with 5 and
50mg/mL showed a relatively similar behavior, with loss
factor values comprised between 0.1 and 0.2.
The data resulting from swelling and degradation studies
showed that it is possible to tailor both water uptake and
weight loss by means of using different ratios of HAGG and
LAGG. Regarding the degradation studies, the higher deg-
radation shown by GG hydrogel matrices composed of 75%
HAGG:25% LAGG (v/v) can be related with the pore size
(Fig. 7). In fact, the SEM images of freeze-dried scaffolds
comprising 75% HAGG:25% LAGG (v/v) revealed pores
possessing a lower pore diameter as compared to others.
Thus, it can be stated that it is possible to adjust the degra-
dation rate of these hydrogels by using different ratios of
HAGG and LAGG.
Two-dimensional in vitro studies: Screening cytotoxicity
A L929 cell line was used to screen the possible cytotox-
icity of the leachables released by the developed GG hy-
drogels. The results showed that for all the periods tested,
the L929 cells remained metabolically active after contacting
with the different extract fluids. All the materials have
shown no statistical differences as compared to the negative
control, and therefore it is possible to state that these GG
formulations are noncytotoxic over L929 cells. According to
what was expected, a clear toxic effect on cell viability was
produced by latex (positive control for cell death).
FIG. 10. Images of the L929
cells encapsulated within dif-
ferent GG MPs loaded into
GG discs: (A) LAGG 2%, (B)
75% HAGG:25% LAGG
(50mg/mL MPs), (C) 50%
HAGG:50% LAGG (50mg/
mL MPs), and (D) 25%
HAGG:75% LAGG (50mg/
mL MPs). The loaded discs
were stained with Calcein-
AM, and cultured for 24 until
72 h. Color images available
online at www.liebertonline
.com/tec
Table 1. Peak Assignment of the Characteristic
Bands Revealed by Fourier-Transform Infrared
Spectra of High Acyl Gellan Gum and Low
Acyl Gellan Gum Powders
Peak (cm - 1) Assignment
1 3420 O-H stretching peak
2 2920 C-H stretching
3 1748 C-O stretching
4 1618 Asymmetric COO- stretching
5 1536 C-C stretching
6 1412 Symmetric COO- stretching
7 1037 C-O stretching
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In vitro 3D study: Cell-loaded GG
MP/hydrogel matrices
A 3D network reported for alginate beads is able to pre-
serve the cells phenotype, leading to normal performance of
cells without changes at the cellular and molecular level.22
Thus, to conclude on which is the best GG formulation to
encapsulate cells, we carried out complementary in vitro
studies. The presence of acyl groups in HAGG is expected to
improve the biological performance, so it is likely that for-
mulations with higher percentage of HAGG could enhance
the biological behavior. By performing the nuclei staining,
we were not able to conclude on the cells viability. To cir-
cumvent this issue, a Calcein AM assay was performed. As it
was shown in Calcein AM images, a concentric cell popu-
lation of metabolically active cells was observed by emission
of green fluorescence. This study has shown positive results
for all formulations, as live cells were seen within the hy-
drogels up to 72 h of culturing. However, these viability
experiments did not enable us to conclude on the cellular
adhesion to the material and cellular proliferation.
In this work, we have proposed the use of GG hydrogel
matrices with cell-loaded MPs as novel systems for appli-
cation in NP regeneration. The combination of HAGG and
LAGG had resulted in different formulations, which were
investigated physicochemically and biologically. The me-
chanical analysis demonstrated the improvement of me-
chanical performance of the hydrogel matrices reinforced
with 50mg/mL of MPs. Moreover, the 25% HAGG:75%
LAGG (v/v) GG hydrogel matrix is the closest substitute of
NP in respect to mechanical properties. Besides the better
results revealed in terms of mechanical behavior, the MPs
allowed cell encapsulation and a good distribution of cells/
MPs within the GG matrices. The biocompatibility studies
demonstrated that the developed GG formulations were
noncytotoxic over L929 cells. Moreover, the in vitro cell en-
capsulation studies revealed that L929 cells encapsulated in
the GG MPs/hydrogel matrices remained viable for 72 h. As
a final remark, the GG hydrogel matrices reinforced with
cell-loaded MPs appears to be a suitable strategy for develop-
ing injectable substitutes for the efficient regeneration of NP.
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